PHARMACOKINETICS OF A NEW ANTICANCER DRUG, NAVELBINE, IN PATIENTS - COMPARATIVE-STUDY OF RADIOIMMUNOLOGIC AND RADIOACTIVE DETERMINATION METHODS

被引：55

作者：

BORE, P

RAHMANI, R

VANCANTFORT, J

FOCAN, C

CANO, JP

机构：

[1] FAC PHARM MARSEILLE,INSERM,U278,PHARMACOCINET LAB,27 BD JEAN MOULIN,F-13385 MARSEILLE 4,FRANCE

[2] UNIV LIEGE,INST PATHOL,B-4000 SART TILMAN,BELGIUM

[3] MONTAGNE ST WALBURGE,CLIN ST ELISABETH,B-4000 LIEGE,BELGIUM

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 23卷 / 04期

关键词：

D O I：

10.1007/BF00451650

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：247 / 251

页数：5

共 18 条

[1]

BENDER RA, 1977, CLIN PHARMACOL THER, V22, P430

[2]

CANO JP, 1986, 5TH NCI EORTC S NEW

[3]

CANO JP, 1985, RECENT ADV CHEMOTHER, P118

[4]

FAVRE R, 1985, RECENT ADV CHEMOTHER, P641

[5]

GIBALDI M, 1982, PHARMACOKINETICS, V15

[6] EXPERIMENTAL ANTITUMOR-ACTIVITY OF 5'-NOR-ANHYDROVINBLASTINE NAVELBINE [J].

MARAL, R ;

BOURUT, C ;

CHENU, E ;

MATHE, G .

CANCER LETTERS, 1984, 22 (01) :49-54

[7]

NELSON RL, 1979, CANCER CHEMOTH PHARM, V2, P243

[8]

OWELLEN RJ, 1975, CANCER RES, V35, P975

[9]

OWELLEN RJ, 1977, CANCER RES, V37, P2597

[10]

POTIER P, 1979, CR SOC BIOL, V173, P414

← 1 2 →